Video

Marianne M. Glanzman, MD: Helping ADHD Patients Succeed

Author(s):

Dr. Glanzman presented during AAP 2021 about executive function impairments in patients with ADHD.

Helping a student with attention deficit/hyperactivity disorder (ADHD) matriculate through school takes a committed effort from parents, physicians, teachers, administrators, family members, and friends.

This is especially true during the COVID-19 pandemic, where the transition to hybrid or virtual schooling has become a challenge for students with ADHD to maintain a steady routine.

Recently, during the 2021 American Academy of Pediatrics (AAP) virtual conference, Marianne M. Glanzman, MD, Attending Physician, Department of Developmental and Behavioral Pediatrics, Children’s Hospital of Philadelphia (CHOP), presented a session about executive function in patients with ADHD.

Executive functions are basically the ability to accomplish goal-directed behavior, including working memory, behavioral inhibition, and cognitive flexibility. However, Glanzman said those are most common impairments, they are not the only impairments. In fact there are about 33 different constructs considered part of executive function.

In an interview with HCPLive®, Glanzman explained how important it is for all aspects of the patient’s life to be pulling in the same direction and executive function should be a major part of that.

She said 1 area where ADHD care can improve is physicians should give parents guidance on how ADHD impacts executive function and what they can do to better help their child.

“As this term executive function becomes much, much more front and center in the world of ADHD, I think parents are going to be asking physicians for advice on this topic,” Glanzman said.

Related Videos
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
© 2024 MJH Life Sciences

All rights reserved.